How many employees does Revance Therapeutics have?
Revance Therapeutics, Inc. has approximately 923 total employees worldwide as of June 2026, according to Revelio Labs workforce intelligence data. Revance Therapeutics’s total headcount has declined 4.6% from 967 employees in 2023 to 923 in 2026.
Is Revance Therapeutics hiring right now?
Yes, Revance Therapeutics is actively hiring. Revance Therapeutics had 95 active job postings in 2026, a 122.0% increase from 2025 — see job openings & hiring trends.
About Revance Therapeutics’s Workforce
Revance Therapeutics, Inc. is a Pharmaceuticals company founded in 1999 and headquartered in Nashville, Tennessee. It employs 923 people worldwide as of June 2026 and sits as the 5th-largest by headcount among its peers.
Revance Therapeutics's workforce fell 4.6% from 2023 to 2026, and it decreased by 0.2% year over year in 2026. The headcount trajectory shows a low of 816 in 2024 Q4, before a recovery. The bulk of employees are in North America (95.3%), with smaller shares in Western Europe (2.2%), Northern Europe (1.9%), and tiny portions in Southeast Asia, Southern Europe, and South America.
Revance Therapeutics's groups are Finance and Operations (46.5% of headcount), Engineering (27.3%), and Sales and Marketing (26.2%), with Finance and Operations the fastest-growing segment at 10.3%. The average company-wide salary is $153,948, with regional medians of $131,000 in Western Europe and $105,000 in Northern Europe, and overall pay up 1.1% year over year in 2026. Hiring activity mirrors the surge in demand, as postings rose 122% in 2026 to 95 active postings, with new postings per month increasing from 36 in 2023 to 68 in 2026.
Revance Therapeutics's sentiment remains neutral but improving, and the company sits at the 5th position by headcount among its peers out of 11 total, reflecting its relative size in the peer group.
Revance Therapeutics's strongest differentiator is a sharp surge in hiring demand (open roles), underscoring a rapid expansion in recruitment activity despite mixed sentiment and a modest overall headcount change.
Sourced from Revelio Labs workforce data.
- Headquarters
- Nashville, Tennessee
- Founded
- 1999
- Industry
- Pharmaceuticals
- Employees
- 923
- YoY
- -0.2% (+96)
As of June 2026
Revance Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Revance Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsRevance Therapeutics Annual Employee Count (2023-2026)
- Revance Therapeutics had 923 employees in 2026, a 0.2% decline (+96) from 2025.
- Revance Therapeutics had 844 employees in 2025, a 7.0% decline (+28) from 2024.
- Revance Therapeutics had 816 employees in 2024, a 5.4% decline (-92) from 2023.
- Revance Therapeutics had 908 employees in 2023, a 4.3% decline (+59) from 2022.
Revance Therapeutics's total workforce has grown from 816 employees in 2024 to 923 in 2026. Revance Therapeutics's headcount peaked at 967 in 2023 before declining in 2024 and recovering through 2025 and 2026.
Revance Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q2 | 923 | +96 | -0.2% |
| 2026 | Q1 | 905 | +85 | -1.6% |
| 2025 | Q4 | 844 | +28 | -7.0% |
| 2025 | Q3 | 827 | -15 | -9.2% |
| 2025 | Q2 | 827 | -32 | -7.6% |
| 2025 | Q1 | 820 | -53 | -9.0% |
| 2024 | Q4 | 816 | -92 | -5.4% |
| 2024 | Q3 | 842 | -125 | -7.9% |
| 2024 | Q2 | 859 | -130 | -9.4% |
| 2024 | Q1 | 873 | -58 | -6.7% |
| 2023 | Q4 | 908 | +59 | -4.3% |
| 2023 | Q3 | 967 | +133 | +0.7% |
See Revance Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataRevance Therapeutics Employee Count by Region (2026)
North America accounts for the largest share of Revance Therapeutics's global workforce with approximately 95% of total employees, followed by Western Europe and Northern Europe.
Revance Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 863 | 95.3% |
| Western Europe | 20 | 2.2% |
| Northern Europe | 17 | 1.9% |
| Southeast Asia | 2 | 0.2% |
| Southern Europe | 2 | 0.2% |
| South America | 1 | 0.1% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataRevance Therapeutics Employee Count by Department (2026)
Revance Therapeutics's employee groups are Finance and Operations (46.5%), Engineering (27.3%), and Sales and Marketing (26.2%).
Revance Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 430 | 46.5% |
| Engineering | 252 | 27.3% |
| Sales and Marketing | 242 | 26.2% |
Compare Revance Therapeutics's department mix to industry peers.
See Full DataRevance Therapeutics Employee Salary by Region (2026)
Revance Therapeutics's average employee salary is $153,948 globally. Employees in Western Europe receive the highest compensation. Pay is lowest in Northern Europe, at a median of $105,000.
Revance Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $131,000 |
| North America | $126,000 |
| Northern Europe | $105,000 |
Unlock salary by role, level, and city — and compare to Revance Therapeutics's industry peers.
Unlock Salary DataRevance Therapeutics Job Openings and Hiring Trends (2023-2026)
- Revance Therapeutics had 95 active job postings in 2026, a 122.0% increase (+34) from 2025.
- Revance Therapeutics had 61 active job postings in 2025, a 129.7% increase (+48) from 2024.
- Revance Therapeutics had 13 active job postings in 2024, a 20.7% decline (-3) from 2023.
- Revance Therapeutics had 16 active job postings in 2023, a 83.6% decline from 2022.
- Hiring velocity in 2026: 68 new roles/month, up from 26 in 2025 and 23 in 2024.
Revance Therapeutics's hiring is accelerating: active job postings rose 122.0% in 2026 to 95, with new postings per month climbing from 36 in 2023 to 68 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataRevance Therapeutics Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Revance Therapeutics's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Revance Therapeutics
- How fast is Revance Therapeutics growing?
- In 2026, Revance Therapeutics's headcount shrank 0.2% to 923 employees, up from 827 in 2025.
- See the full headcount history
- Where are Revance Therapeutics employees located?
- Most Revance Therapeutics employees are based in North America (95.3% of headcount), followed by Western Europe and Northern Europe.
- Explore where the workforce is based
- How many people work at Revance Therapeutics in North America?
- About 863 people work at Revance Therapeutics in North America, its largest region.
- See headcount by region
- What is the average salary at Revance Therapeutics?
- The average employee salary at Revance Therapeutics is approximately $153.9k per year.
- Analyze the salary distribution
- How many new job postings does Revance Therapeutics open per year?
- Through Q2 2026, Revance Therapeutics opened 409 new job postings. In 2025, Revance Therapeutics opened 316 new job postings — about 26 per month.
- Track hiring trends by role
- When was Revance Therapeutics founded and where is it headquartered?
- Revance Therapeutics was founded in 1999 and is headquartered in Nashville, Tennessee.
- Compare Revance Therapeutics to industry peers
Speak with a workforce expert about Revance Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.